Shopping Cart
- Remove All
- Your shopping cart is currently empty
Triptorelin is a GnRH agaonist shown to inhibit estradiol-induced cancer cell proliferation
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $38 | Backorder | |
5 mg | $56 | Backorder | |
10 mg | $75 | Backorder | |
25 mg | $98 | Backorder | |
50 mg | $126 | Backorder | |
100 mg | $162 | Backorder |
Description | Triptorelin is a GnRH agaonist shown to inhibit estradiol-induced cancer cell proliferationIn vivo: (1) Triptorelin can improve the pregnancy rate by 12% to 15% in ewes6 and downregulate ovarian GnRHR-I expression of female rats, especially in late-growing follicles.(2) Triptorelin immunity blocked EET and UWT, inhibited uterine growth and development and enhance the expression levels s of ESR1, LHR, and FSHR proteins. [1]. Wei S et al. Triptorelin and cetrorelix induce immune responses and affect uterine development and expressions of genes and proteins of ESR1, LHR, and FSHR of mice. Immunopharmacol Immunotoxicol. 2016 Jun;38(3):197-204. |
In vivo | (1) Triptorelin can improve the pregnancy rate by 12% to 15% in ewes6 and downregulate ovarian GnRHR-I expression of female rats, especially in late-growing follicles.(2) Triptorelin immunity blocked EET and UWT, inhibited uterine growth and development and enhance the expression levels s of ESR1, LHR, and FSHR proteins. |
Molecular Weight | 1311.45 |
Formula | C64H82N18O13 |
Cas No. | 57773-63-4 |
Relative Density. | 1.52 g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||
Solubility Information | DMF: 10 mg/mL (7.63 mM), Sonication is recommended. PBS (pH 7.2): 3 mg/mL (2.29 mM), Sonication is recommended. DMSO: 3 mg/mL (2.29 mM), Sonication is recommended. | ||||||||||
Solution Preparation Table | |||||||||||
PBS (pH 7.2)/DMSO/DMF
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.